Marengo Doses First Patient in Phase 2 Study for Invikafusp Alfa
20 Dec 2024 //
PR NEWSWIRE
Ipsen, Marengo ink $1.2B biobuck deal to treat cold tumors
08 Jun 2024 //
FIERCE BIOTECH
Ipsen, Marengo Partner On Tri-STAR Precision T-Cell Engagers
07 Jun 2024 //
GLOBENEWSWIRE
Marengo Presents Preclinical Data Supporting Invg of its Lead Asset, STAR0602
10 Nov 2022 //
PRNEWSWIRE
Marengo Therapeutics Presents Preclinical Proof-of Concept Data for STAR0602
28 Oct 2022 //
PRNEWSWIRE
Ipsen & Marengo Announce Strategic Partnership
01 Aug 2022 //
BUSINESSWIRE
Marengo`s STAR shines as Ipsen pays $45M for 2 cancer drugs
01 Aug 2022 //
FIERCEBIOTECH
Marengo Tx to Participate in Investor, Scientific, Industry Conferences
09 Mar 2022 //
PRNEWSWIRE
Marengo to Present at Annual J.P. Morgan Health Care Conference
06 Jan 2022 //
PRNEWSWIRE